Almenoff June Sherie Insider Trades

Insider Trading History

Track insider trading activity for Almenoff June Sherie. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Tenax Therapeutics
Tenax Therapeutics TENX
Director
Holding Value $333k 30,000 shares
Last Trade
Jan 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$399k 30,000 shares
$13.30
$11.09
Tenax Therapeutics
Tenax Therapeutics TENX
Director
Holding Value $22.1k 1,993 shares
Last Trade
Nov 18, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$14.3k 1,900 shares
$7.52
$11.09
Tenax Therapeutics
Tenax Therapeutics TENX
Director
Holding Value $1.03k 93 shares
Last Trade
Nov 17, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$665 93 shares
$7.15
$11.09
Tenax Therapeutics
Tenax Therapeutics TENX
Director
Holding Value $887k 80,000 shares
Last Trade
Jul 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$460k 80,000 shares
$5.75
$11.09
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $274k 20,100 shares
Last Trade
Jun 17, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$89.8k 20,100 shares
$4.47
$13.61
Actinium Pharmaceuticals
Actinium Pharmaceuticals ATNM
Director
Holding Value $0 0 shares
Last Trade
Mar 31, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$85.5k 50,000 shares
$1.71
$1.11
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $43.1k 3,167 shares
Last Trade
Mar 28, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$26.8k 3,167 shares
$8.46
$13.61
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $86.2k 6,333 shares
Last Trade
Mar 28, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$26.8k 3,167 shares
$8.46
$13.61
Tenax Therapeutics
Tenax Therapeutics TENX
Director
Holding Value $1.11M 100,000 shares
Last Trade
Dec 10, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$594k 100,000 shares
$5.94
$11.09
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $13.6k 1,000 shares
Last Trade
Nov 13, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$6.5k 500 shares
$13.00
$13.61
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $6.81k 500 shares
Last Trade
Nov 12, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$6.25k 500 shares
$12.50
$13.61
Actinium Pharmaceuticals
Actinium Pharmaceuticals ATNM
Director
Holding Value $55.5k 50,000 shares
Last Trade
Nov 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$85.5k 50,000 shares
$1.71
$1.11
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $335k 24,600 shares
Last Trade
Aug 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$243k 24,600 shares
$9.88
$13.61
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $45.4k 3,334 shares
Last Trade
Dec 20, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$34.4k 3,334 shares
$10.32
$13.61
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $62.3k 4,575 shares
Last Trade
Jun 30, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$390k 4,575 shares
$85.25
$13.61
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $15.9k 1,167 shares
Last Trade
Mar 31, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$490k 1,167 shares
$420.00
$13.61
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $5.58k 410 shares
Last Trade
Dec 30, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$496k 410 shares
$1,209.62
$13.61
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $8.23k 605 shares
Last Trade
Sep 30, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$482k 605 shares
$796.80
$13.61
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $59k 4,338 shares
Last Trade
Jun 30, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$12.5M 8,676 shares
$1,440.00
$13.61
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $544k 40,000 shares
Last Trade
Jun 14, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$102M 80,000 shares
$1,270.08
$13.61

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up